Smitha S. Krishnamurthi, MD, on Colorectal Cancer: Treatment Updates

May 19, 2022 By The ASCO Post Staff

Smitha S. Krishnamurthi, MD, of the Cleveland Clinic Taussig Cancer Institute, discusses prognostic assays for localized colon cancer, the potential clinical uses and current limitations of prognostic assays for stage II to III disease, and checkpoint inhibitor therapy for metastatic colorectal cancer.

Related Content